Geode Capital Management LLC Boosts Stake in Astera Labs, Inc. $ALAB

Geode Capital Management LLC grew its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 36.2% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 1,244,978 shares of the company’s stock after acquiring an additional 330,841 shares during the period. Geode Capital Management LLC’s holdings in Astera Labs were worth $112,562,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Straight Path Wealth Management increased its position in Astera Labs by 1.5% during the 2nd quarter. Straight Path Wealth Management now owns 6,850 shares of the company’s stock worth $619,000 after purchasing an additional 100 shares in the last quarter. First Horizon Advisors Inc. lifted its position in Astera Labs by 12.4% during the second quarter. First Horizon Advisors Inc. now owns 982 shares of the company’s stock valued at $89,000 after buying an additional 108 shares in the last quarter. Wealthcare Advisory Partners LLC grew its stake in Astera Labs by 0.8% during the second quarter. Wealthcare Advisory Partners LLC now owns 29,160 shares of the company’s stock worth $2,637,000 after buying an additional 221 shares during the period. Sound Income Strategies LLC increased its position in shares of Astera Labs by 31.1% in the second quarter. Sound Income Strategies LLC now owns 1,038 shares of the company’s stock worth $94,000 after acquiring an additional 246 shares in the last quarter. Finally, Oliver Lagore Vanvalin Investment Group acquired a new stake in shares of Astera Labs in the second quarter worth $29,000. 60.47% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on ALAB shares. Zacks Research lowered shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, October 6th. CICC Research began coverage on Astera Labs in a research report on Friday, August 29th. They issued an “outperform” rating and a $190.00 price objective on the stock. Cowen reaffirmed a “hold” rating on shares of Astera Labs in a research report on Wednesday, November 5th. Deutsche Bank Aktiengesellschaft increased their target price on Astera Labs from $160.00 to $200.00 and gave the company a “buy” rating in a research note on Tuesday, September 2nd. Finally, Evercore ISI boosted their price target on Astera Labs from $104.00 to $215.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 6th. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $187.06.

Astera Labs Price Performance

NASDAQ:ALAB opened at $139.29 on Friday. The firm has a 50-day moving average of $186.87 and a two-hundred day moving average of $145.27. The stock has a market cap of $23.53 billion, a P/E ratio of 125.49, a PEG ratio of 2.65 and a beta of 1.37. Astera Labs, Inc. has a 1-year low of $47.13 and a 1-year high of $262.90.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.39 by $0.10. The business had revenue of $230.58 million for the quarter, compared to analysts’ expectations of $206.42 million. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The company’s revenue was up 103.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.23 earnings per share. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. As a group, equities analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Insider Buying and Selling

In other news, CFO Michael Truett Tate sold 11,430 shares of the stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $1,653,806.70. Following the completion of the transaction, the chief financial officer directly owned 192,297 shares in the company, valued at approximately $27,823,452.93. This represents a 5.61% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, COO Sanjay Gajendra sold 90,459 shares of Astera Labs stock in a transaction on Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the completion of the sale, the chief operating officer owned 1,599,750 shares of the company’s stock, valued at approximately $231,467,827.50. This trade represents a 5.35% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 619,436 shares of company stock worth $96,530,060 over the last 90 days. 12.50% of the stock is currently owned by corporate insiders.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.